Cyclin N-Terminal Domain Containing Protein 2 (CNTD2)
Aurora-A is a mitotic kinase, which regulates cell cycle progression through modulating centrosome function. Aurora-A expression is frequently altered in human malignancies. CNTD2 as a novel Aurora-A partner and oncogene to activate Aurora-A and induce transformation. CNTD2 locates to chromosome 19q13.2 AKT2 amplicon. CNTD2 is amplified and overexpressed in human ovarian, pancreatic and lung cancer cell lines and primary tumors. CNTD2 colocalizes and interacts with Aurora-A in the centrosome. CNTD2 expression induces Aurora-A and cdc2 kinase activity, G2/M progression, and malignant transformation. These data indicate that CNTD2 is an oncogene and could play a pivotal role in Aurora-A activation during the cell cycle and that disruption of CNTD2-Aurora-A axis may represent a potential means to antitumor drug discovery.
Organism species: Homo sapiens (Human)
- Customized Service n/a Recombinant Cyclin N-Terminal Domain Containing Protein 2 (CNTD2) Recombinant Protein Customized Service Offer
- Customized Service n/a Monoclonal Antibody to Cyclin N-Terminal Domain Containing Protein 2 (CNTD2) Monoclonal Antibody Customized Service Offer
- Customized Service n/a Polyclonal Antibody to Cyclin N-Terminal Domain Containing Protein 2 (CNTD2) Polyclonal Antibody Customized Service Offer
- Customized Service n/a CLIA Kit for Cyclin N-Terminal Domain Containing Protein 2 (CNTD2) CLIA Kit Customized Service Offer
- Customized Service n/a ELISA Kit for Cyclin N-Terminal Domain Containing Protein 2 (CNTD2) ELISA Kit Customized Service Offer
